Taste acuity improvement - objective outcome (continuous) - individual taste sensations · Patients with taste disturbances (dysgeusia/hypogeusia; idiopathic, zinc-deficient, or secondary to chronic renal failure)
Zinc supplements (zinc sulphate, zinc gluconate, zinc picolinate,… showed no clear difference in taste acuity improvement - objective outcome (continuous) -… compared with placebo; GRADE not reported.
1 finding from 1 review
Interventions for managing taste disturbances 2017 · Cochrane All outcomesChronic renal failure
Results (Mahajan 1980, chronic renal failure; Analysis 1.3): mean difference by taste sensation - salt MD 285 (95% CI 238.75 to 331.25); sweet MD 190 (142.36 to 237.64); sour MD 10 (-16.43 to 36.43); bitter MD 2.40…
1 study · 22 participants
GRADE not reported
Group programme compared to face‐to‐face individual intervention · people who smoke
Group‐format behavioural programmes showed no clear difference in group programme compared to face‐to‐face individual intervention compared with alternative support (moderate certainty).
1 finding from 1 review
Intervention not reported
Residual pleural fluid on chest X‐ray at 8 weeks · adults and adolescents with pleural TB
The intervention may leads to lower residual pleural fluid on chest X‐ray at 8 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Residual pleural fluid on chest X‐ray at 24 weeks · adults and adolescents with pleural TB
The intervention may leads to lower residual pleural fluid on chest X‐ray at 24 weeks (low certainty).
1 finding from 1 review
Smoking cessation · young people
Behavioural interventions showed no clear difference in individual counselling (in‐person) vs control Smoking cessation compared with minimal control (low certainty).
1 finding from 1 review
Intervention not reported
Global state: No clinically important overall improvement (as rated by individual trials) ‐ medium term ( · People with schizophrenia and schizophrenia‐like disorders
The intervention may leads to lower global state: No clinically important overall improvement (as rated… (low certainty).
1 finding from 1 review
Intervention not reported
Treatment 2: individual instillation of topical gatifloxacin 0.3% and prednisolone acetate 1% · participants undergoing cataract surgery
1 finding from 1 review
no estimate extracted
108 participants
Very low
Global state: clinically important change in global state · patients with schizophrenia
1 finding from 1 review
Functioning: clinically important change in general functioning, as defined by individual studies · patients with schizophrenia
1 finding from 1 review
Global state: clinically important change in global state · patients with schizophrenia
1 finding from 1 review
Functioning: clinically important change in general functioning, as defined by individual studies · patients with schizophrenia
1 finding from 1 review
Mental state: clinically important response, as defined by individual studies * · patients with schizophrenia
1 finding from 1 review
Functioning: clinically important change in general functioning, as defined by individual studies · patients with schizophrenia
1 finding from 1 review
Global state: clinically important change in global state · patients with schizophrenia
1 finding from 1 review
Mental state: clinically important response, as defined by individual studies * · patients with schizophrenia
1 finding from 1 review
NSI‐ change in level ‐ Gradual introduction · preventing percutaneous exposure injuries caused by needles in healthcare personnel
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Low
NSI‐ Change in slope ‐ Gradual introduction · preventing percutaneous exposure injuries caused by needles in healthcare personnel
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Low
Engagement with services: clinically important change in engagement with services, as defined by individual studies · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment adherence: clinically important change in treatment adherence, as defined by individual studies · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Understanding: clinically important change in understanding the nature of illness and its outcome, as defined by individual studies · people with schizophrenia and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found